Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Total	Common Stock	Additional Paid-In-Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at beginning at Dec. 31, 2021	$ 169,109,000	$ 4,000	$ 479,436,000	$ (27,000)	$ (310,304,000)
Balance at beginning (in shares) at Dec. 31, 2021		34,900,727
Exercise of stock options	147,000		147,000
Exercise of stock options (in shares)		122,208
Stock-based compensation expense	3,311,000		3,311,000
Net unrealized loss on short-term marketable securities	(3,000)			(3,000)
Net loss	(26,029,000)				(26,029,000)
Balance at ending at Mar. 31, 2022	146,535,000	$ 4,000	482,894,000	(30,000)	(336,333,000)
Balance at ending (in shares) at Mar. 31, 2022		35,022,935
Balance at beginning at Dec. 31, 2021	169,109,000	$ 4,000	479,436,000	(27,000)	(310,304,000)
Balance at beginning (in shares) at Dec. 31, 2021		34,900,727
Net loss	(112,033,000)
Balance at ending at Dec. 31, 2022	326,562,000	$ 5,000	748,857,000	37,000	(422,337,000)
Balance at ending (in shares) at Dec. 31, 2022		46,865,206
Exercise of stock options	$ 456,000		456,000
Exercise of stock options (in shares)	105,783	105,783
Common stock issued for Vested restricted stock units, Shares		8,067
Vested warrants issued pursuant to loan agreement	$ 330,000		330,000
Stock-based compensation expense	4,844,000		4,844,000
Net unrealized loss on short-term marketable securities	(16,000)			(16,000)
Net loss	(25,831,000)				(25,831,000)
Balance at ending at Mar. 31, 2023	$ 306,345,000	$ 5,000	$ 754,487,000	$ 21,000	$ (448,168,000)
Balance at ending (in shares) at Mar. 31, 2023		46,979,056